OncoTAb develops a continuum of products from early detection to treatment of epithelial cancers. Current products on the market and under development address unmet needs in the detection and treatment of pancreatic cancer as well as triple negative and metastatic breast cancer.
146 Grigg Hall, 9201 University City Blvd.
Employment range in NC
Primary site activity
All company activities
Potential end market(s)
Products on market
Agkura Personal Score - test to detect growth of epithelial cancers (breast, pancreas, etc.)
Products under development
Radiolabeled Theranostic, Bi-specific T cell engager